Athletics: Semenya releases list of experts for battle with IAAF at CAS

Send a link to a friend  Share

[February 19, 2019]  (Reuters) - Caster Semenya has released a list of experts she will call in her appeal hearing at the Court of Arbitration for Sport (CAS) this week in her fight against regulations aimed at lowering the testosterone levels of hyperandrogenic athletes like her.

The South African 800-metres double Olympic champion on Monday expressed her disappointment after the International Association of Athletics Federations (IAAF) revealed the names of their five witnesses for the proceedings in Lausserne.

She called it a breach of confidentiality rules ahead of a five-day appeal that could have far reaching consequences for sport. The IAAF deny any wrong-doing.

She will call on a range of experts from various fields, and used the announcement of their names, through her lawyers, to reiterate her stance on the IAAF’s proposed regulations.

"The IAAF regulations do not empower anyone," the statement said. "Rather, they represent yet another flawed and hurtful attempt to police the sex of female athletes.

"Ms Semenya’s courage and perseverance in her fight to run free is an inspiration to young athletes in her home country of South Africa and around the globe."



The IAAF regulations stipulate that women with elevated testosterone take medication to reduce their level before being allowed to compete, but only in the middle-distance events of between 400- and 1500-metres where it is claimed the advantage is most felt.

IAAF President Sebastian Coe told reporters on Monday that the regulations are aimed at leveling the field between hyperandrogenic athletes and those with normal levels of testosterone.

The IAAF’s previous attempts to regulate testosterone in female athletes fell foul of a CAS ruling in 2015 following an appeal on behalf of Indian Dutee Chand, who had been banned from competing because of her high levels.

CAS claimed in their judgment that the IAAF had not provided sufficient evidence that hyperandrogenic athletes gained a significant advantage due to their testosterone count.

A verdict could take up to a month, according to CAS.

The experts who will testify in support of Semenya are listed as:

[to top of second column]

South Africa's Caster Semenya arrives at Court of Arbitration for Sport (CAS) with her lawyers in Lausanne, Switzerland, February 18, 2019. REUTERS/Reuters TV

- Prof Veronica Gomez-Lobo, Obstetrics and Gynecology at Georgetown University and the Director of the DSD (Differences of Sexual Development) Clinic at the Children’s National Health System in Washington‚ DC.

- Dr Alun Williams, Director of the Sports Genomics Laboratory at Manchester Metropolitan University.

- Professor Eric Vilain, specialist in gender-based and endocrine genetics‚ including DSD, who has consulted to the International Olympic Committee (IOC).

- Professor Roger Pielke Jr, director of the Sports Governance Center at the University of Colorado.

- Professor Dankmar Böhning, Chair in Medical Statistics at the University of Southampton.

- Professor Richard Holt, expert in Diabetes and Endocrinology at the University of Southampton.

- Professor Anthony C Hackney, University of North Carolina‚ with joint appointments in the Department of Exercise and Sport Science and the Department of Nutrition School of Public Health.

- Dr Lih-Mei Liao, clinical and health psychologist in the United Kingdom who has worked extensively with women diagnosed with a range of DSD conditions.

- Dr Payoshni Mitra, teaches Sport Sociology at Birkbeck College‚ University of London and works closely with athletes with hyperandrogenism and DSD from the Southern Hemisphere.

- Ashley LaBrie‚ Executive Director of AthletesCAN‚ an independent organization that represents the interests of all national team athletes in Canada.

(Reporting By Nick Said; Editing by Amlan Chakraborty)

[© 2019 Thomson Reuters. All rights reserved.]

Copyright 2019 Reuters. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.

Back to top